Single nucleotide polymorphisms of RAD51 G135C, XRCC2 Arg188His and XRCC3 Thr241Met homologous recombination repair genes and the risk of sporadic endometrial cancer in Polish womenjog

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 6, 2012, Pages 918-924

  Romanowicz Makowska, Hanna ^a   Smolarz, Beata ^a   Polać, Ireneusz ^a   Sporny, Stanislaw ^b  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Endometrial cancer; Gene polymorphism; RAD51; XRCC2; XRCC3

Indexed keywords

ARGININE; HISTAMINE; METHIONINE; RAD51 PROTEIN; THREONINE; XRCC3 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; RECOMBINATION REPAIR; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; X RAY REPAIR CROSS COMPLEMENTING GROUP 2 GENE;

EID: 84864580317     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2011.01811.x     Document Type: Article

References (30)

1. Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002; 23: 687-696.
2. Helleday T. Pathways for mitotic homologous recombination in mammalian cells. Mutat Res 2003; 532: 103-115.
3. Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett 2005; 219: 125-135.
4. Costa S, Pinto D, Pereira D et al. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: A study on a Portuguese population. Breast Cancer Res Treat 2007; 103: 209-217.
5. Jara L, Acevedo ML, Blanco R et al. RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population. Cancer Genet Cytogenet 2007; 178: 65-69.
6. Antoniou AC, Sinilnikova OM, Simard J et al. RAD51 135G?C modifies breast cancer risk among BRCA2 mutation carriers: Results from a combined analysis of 19 studies. Am J Hum Genet 2007; 81: 1186-1200.
7. Romanowicz H, Smolarz B, Baszczyński J, Zadrožny M, Kulig A. Genetics polymorphism in DNA repair genes by base excision repair pathway (XRCC1) and homologous recombination (XRCC2 and RAD51) and the risk of breast carcinoma in the Polish population. Pol J Pathol 2010; 61: 206-216.
8. Lee KM, Choi JY, Kang C et al. Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin Cancer Res 2005; 11: 4620-4626.
9. Webb PM, Hopper JL, Newman B et al. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 319-323.
10. Jakubowska A, Gronwald J, Menkiszak J et al. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 2007; 16: 270-275.
11. Krupa R, Sobczuk A, Poplawski T, Wozniak K, Blasiak J. DNA damage and repair in endometrial cancer in correlation with the hOGG1 and RAD51 genes polymorphism. Mol Biol Rep 2011; 38: 1163-1170.
12. San Filippo J, Sung P, Klein H. Mechanism of eukaryotic homologous recombination. Annu Rev Biochem 2008; 77: 229-257.
13. Thacker J, Zdzienicka MZ. The XRCC genes: Expanding roles in DNA double-strand break repair. DNA Repair (Amst) 2004; 3: 1081-1090.
14. Kuschel B, Auranen A, McBride S et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002; 11: 1399-1407.
15. Benhamou S, Tuimala J, Bouchardy C, Dayer P, Sarasin A, Hirvonen A. DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 2004; 112: 901-904.
16. Matullo G, Guarrera S, Sacerdote C et al. Polymorphisms/ haplotypes in DNA repair genes and smoking: A bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev 2005; 14: 2569-2578.
17. Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hankinson SE, Hunter DJ. XRCC2 and XRCC3 polymorphisms are not associated with risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 1090-1091.
18. Han J, Colditz GA, Samson LD, Hunter DJ. Polymorphisms in DNA double-strand break repair genes and skin cancer risk. Cancer Res 2004; 64: 3009-3013.
19. Han J, Hankinson SE, Hunter DJ, De Vivo I. Genetic variations in XRCC2 and XRCC3 are not associated with endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 2004; 13: 330-331.
20. Economopoulos KP, Sergentanis TN. XRCC3 Thr241Met polymorphism and breast cancer risk: A meta-analysis. Breast Cancer Res Treat 2010; 121: 439-443.
21. Jiang Z, Li C, Xu Y, Cai S. A meta-analysis on XRCC1 and XRCC3 polymorphisms and colorectal cancer risk. Int J Colorectal Dis 2010; 25: 169-180.
22. Sun H, Qiao Y, Zhang X et al. XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: A meta-analysis. Cancer Sci 2010; 101: 1777-1782.
23. Sliwinski T, Walczak A, Przybylowska K et al. Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population. Exp Mol Pathol 2010; 89: 358-366.
24. Weiss JM, Weiss NS, Ulrich CM, Doherty JA, Voigt LF, Chen C. Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2524-2530.
25. Pieretti M, Khattar NH, Smith SA. Common polymorphisms and somatic mutations in human base excision repair genes in ovarian and endometrial cancers. Mutat Res 2001; 432: 53-59.
26. Improta G, Sgambato A, Bianchino G et al. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: A case-control study in a Southern Italian population. Anticancer Res 2008; 28: 2941-2946.
27. Lu PH, Li C, Zhou HY et al. Same data sources, different pooled analysis result: The ongoing uncertainty in the subgroup analysis of RAD51 135G/C polymorphism and breast cancer risk. Breast Cancer Res Treat 2011; 125: 299-300.
28. Li F, Li C, Jiang Z, Ma N, Gao X. XRCC3 T241M polymorphism and bladder cancer risk:A meta-analysis. Urology 2011; 77: 511-515.
29. De Ruyck K, Van Eijkeren M, Claes K et al. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: Association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. Int J Radiat Oncol Biol Phys 2005; 62: 1140-1149.
30. Klein HL. The consequences of Rad51 overexpression for normal and tumor cells. DNA Repair (Amst) 2008; 7: 686-693.